UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

  

 

 

Form 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 3, 2016

 

OCEAN BIO-CHEM, INC.

(Exact name of registrant as specified in charter)

 

Florida   0-11102   59-1564329
(State or Other Jurisdiction
of Incorporation)		   (Commission File Number)   (I.R.S. Employer
Identification No.)

 

4041 S.W. 47 Avenue, Fort Lauderdale, Florida 33314

(Address of principal executive offices) (Zip Code)

 

(954) 587-6280

Registrant’s telephone number, including area code:

  

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 
 

 

Item 5.07. Submission of Matters to a Vote of Security Holders

 

Ocean Bio-Chem, Inc. (the “Company”) held its Annual Meeting of Shareholders on June 3, 2016. The proposals submitted by the Board of Directors to a vote of shareholders, and the final results of the vote on each proposal, are set forth below.

 

Proposal No. 1 — Election of Directors

 

The following nominees were elected by shareholders to serve on the Company’s Board of Directors until the next annual meeting of shareholders or until their respective successors have been duly elected and qualified. The voting results with respect to each nominee were as follows:

 

Nominees  For   Withheld   Broker
Non-Votes		 
Jeffrey S. Barocas   6,523,018    792,341    1,341,600 
Sonia B. Beard   7,304,187    11,172    1,341,600 
Diana Mazuelos Conard   7,304,187    11,172    1,341,600 
Gregor M. Dornau   6,523,337    792,022    1,341,600 
Peter G. Dornau   6,533,337    782,022    1,341,600 
William W. Dudman   6,523,337    792,022    1,341,600 
James M. Kolisch   6,523,337    792,022    1,341,600 
John B. Turner   7,304,086    11,273    1,341,600 

 

Proposal No. 2 — Ratification of the Appointment of Independent Registered Public Accounting Firm.

 

The shareholders ratified of the appointment of Goldstein Schechter Koch P.A. as the Company's independent registered public accounting firm for 2016. The voting results were as follows:

 

For   Against   Abstain  

Broker

Non-Votes

8,649,120   7,758   481   0

 

Proposal No. 3 — Advisory Vote on the Compensation of the Company’s Named Executive Officers

 

The shareholders approved, on an advisory basis, the compensation of the Company’s named executive officers. The voting results were as follows:

 

For   Against   Abstain  

Non

    Votes    

7,198,439   113,364   3,956   1,341,600

  

 2 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

  

  OCEAN BIO-CHEM, INC.
     
Date: June 6, 2016 By: /s/ Jeffrey S. Barocas
    Jeffrey S. Barocas
    Chief Financial Officer

 

 

3